The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study

The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study

Rituximab is used to eliminate B cells as a chimeric monoclonal antibody directed against CD20, a B-cell antigen expressed on B cells. To explore the impact of rituximab administered before transplantation, we implemented a retrospective, monocentric study and utilized real-world data collected at o...

Full description

Bibliographic Details
Main Authors: Xiya Wei, Yiyu Xie, Ruoyu Jiang, Huiyu Li, Heqing Wu, Yuqi Zhang, Ling Li, Shiyuan Zhou, Xiao Ma, Zaixiang Tang, Jun He, Depei Wu, Xiaojin Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
rituximab
B cell
prior to transplantation
allogeneic hematopoietic stem cell transplantation
EBV - Epstein-Barr virus
aGVHD: acute graft vs host disease
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.967026/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.967026/full

Similar Items